The Future of Diagnostics: Earlier, Faster, and At-Home
Event Information
Description
Feeling under the weather? Just grab your at-home diagnostic kit to know right away! In the near future, our diagnostics will notify you at the earliest stages of cancer and whether your child has autism before they are born. Early and convenient detection of disease will enable better strategies for intervention and prevention. Come hear four startups building this future!
Light snacks and drinks served.
Speakers:

Lena Cheng, VP of Marketing at Freenome
Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments for millions of patients.

Frankie Myers, Director of Engineering at Diassess
Rapid point-of-care molecular diagnostic assay for infectious disease, starting with the common flu.

Chun-Hao Huang, CEO of Clinicai
Clinicai is building a smart toilet monitor for non-invasive early detection of gastrointestinal cancers and diseases.

John Slattery, CEO of BioROSA
BioROSA enables early detection and improvements in the pediatric diagnostic process for autism by providing clinicians validated blood tests to improve diagnostic certainty.

Anand Parikh, CEO of Chronus Health
Chronus Health is building a portable diagnostic platform that reduces turnaround times for blood tests from days to minutes. Their initial launch for CBC and CMP accounts for 50% of all tests performed.
Agenda:
6:30pm Doors open & networking
7:00pm Talks & panel discussion
8:00pm Networking & IndieBio tour